Trial 0C-21-9


A Phase 1a/1b Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors

Type: Treatment
Phase: Phase I
Status: Open to Accrual
Treatments: Other
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Anthony El-Khoueiry, M.D.
Other Trial Staff:  Lorraine Martinez, Coordinator, Nicole Jensen, Coordinator, Xiomara Menendez, R.N., Jessica Levano, Coordinator, Khatchik Karakozian, D.M., Negeen Izadian, Coordinator, Diane Habib, Coordinator, Judy Smith, Coordinator, Stephanie Kim, Coordinator, Maura Fernandez, D.M.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.